AMYLYX-PHARMACEUTICALS Press Release Archive
Xconomy: Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer's
Fierce Biotech Names Amylyx Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2020 | Business Wire
Amylyx wins approval for first ALS drug - Boston Business Journal
Media
Amylyx Company Profile: Stock Performance & Earnings | PitchBook
Media
Amylyx Pharmaceuticals Announces FDA Advisory Committee Will Reconvene to Review New Drug Application for AMX0035 for the Treatm
Amylyx eyes IPO to support ALS drug filings across the world after FDA U-turn | Fierce Biotech
ALS drug wins FDA approval despite questionable data
Amylyx Updates - I AM ALS
Amylyx Pharmaceuticals Inc. - Posts | Facebook
Gina Mazzariello on LinkedIn: I am excited and privileged to join Amylyx Pharmaceuticals and support
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IOKLMV5D5RNP7FTEWUHMHQCFGU.jpg "Amylyx's ALS drug gets U.S. FDA panel's backing in rare turnaround | Reuters")
Amylyx's ALS drug gets U.S. FDA panel's backing in rare turnaround | Reuters
Media
Media
Amylyx to Seek AMX0035's Approval for ALS in Europe
Amylyx Pharmaceuticals Inc.: Stock Market News and Information
Relyvrio Approved as ALS Treatment by the FDA - Xtalks
Amylyx - FINN Partners
Amylyx Enrolls First ALS Patients in Phase 2 Extension Trial of AMX0035
FDA sets decision date for Amylyx Pharma ALS drug that improves neuron survival - MedCity News
Media
